Janus Dendrimers to Assess the Anti-HCV Activity of Molecules in Cell-Assays

The use of nanocarriers has been revealed as a valid strategy to facilitate drug bioavailability, and this allows for expanding the drug libraries for the treatment of certain diseases such as viral diseases. In the case of Hepatitis C, the compounds iopanoic acid and 3,3′,5-triiodothyroacetic acid...

Descripción completa

Detalles Bibliográficos
Autores principales: San Anselmo, María, Lancelot, Alexandre, Egido, Julia E., Clavería-Gimeno, Rafael, Casanova, Álvaro, Serrano, José Luis, Hernández-Ainsa, Silvia, Abian, Olga, Sierra, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695217/
https://www.ncbi.nlm.nih.gov/pubmed/33171841
http://dx.doi.org/10.3390/pharmaceutics12111062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695217/
https://www.ncbi.nlm.nih.gov/pubmed/33171841
http://dx.doi.org/10.3390/pharmaceutics12111062

Ejemplares similares